NK1 receptor antagonism and the neural processing of emotional information in healthy volunteers.
The neuropeptide substance P and its receptor NK1 have been implicated in emotion, anxiety and stress in preclinical studies. However, the role of NK1 receptors in human brain function is less clear and there have been inconsistent reports of the value of NK1 receptor antagonists in the treatment of clinical depression. The present study therefore aimed to investigate effects of NK1 antagonism on the neural processing of emotional information in healthy volunteers. Twenty-four participants were randomized to receive a single dose of aprepitant (125 mg) or placebo. Approximately 4 h later, neural responses during facial expression processing and an emotional counting Stroop word task were assessed using fMRI. Mood and subjective experience were also measured using self-report scales. As expected a single dose of aprepitant did not affect mood and subjective state in the healthy volunteers. However, NK1 antagonism increased responses specifically during the presentation of happy facial expressions in both the rostral anterior cingulate and the right amygdala. In the emotional counting Stroop task the aprepitant group had increased activation in both the medial orbitofrontal cortex and the precuneus cortex to positive vs. neutral words. These results suggest consistent effects of NK1 antagonism on neural responses to positive affective information in two different paradigms. Such findings confirm animal studies which support a role for NK1 receptors in emotion. Such an approach may be useful in understanding the effects of novel drug treatments prior to full-scale clinical trials.
McCabe
Ciara
C
University Department of Psychiatry, Warneford Hospital, Oxford, UK. ciara.mccabe@psych.ox.ac.uk
Cowen
Philip J
PJ
Harmer
Catherine J
CJ
D000293:Adolescent; D000328:Adult; D000339:Affect; D000679:Amygdala / Q000187:drug effects / Q000378:metabolism; D000077608:Aprepitant; D001931:Brain Mapping / Q000379:methods; D004311:Double-Blind Method; D004644:Emotions; D005149:Facial Expression; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D008606:Mental Processes / Q000187:drug effects*; D009025:Morpholines / Q000494:pharmacology*; D009434:Neural Pathways / Q000187:drug effects*; D064729:Neurokinin-1 Receptor Antagonists; D010364:Pattern Recognition, Visual / Q000187:drug effects; D010775:Photic Stimulation; D017397:Prefrontal Cortex / Q000187:drug effects* / Q000378:metabolism; D018040:Receptors, Neurokinin-1 / Q000378:metabolism; D055815:Young Adult
D009025:Morpholines; D064729:Neurokinin-1 Receptor Antagonists; D018040:Receptors, Neurokinin-1; D000077608:Aprepitant